Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...

Companies unite in shared vision of enabling researchers to translate genomic insights to groundbreaking discoveries Partnership includes launch of new IDT xGen™ NGS products designed exclusively for ...

Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...

The FDA issued two policies April 12 to establish approaches for the design and validation of next-generation sequencing tests. Next-generation sequencing tests review a person’s DNA to diagnose ...

To mark the launch, Volta Labs and Watchmaker Genomics will host a joint in suite presentation at AGBT 2026 on February 24 at 8:30 a.m. in the Fulton Suite, where attendees can learn more about the ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched the Twist TrueAmp ...

This eBook explores next-generation sequencing (NGS) methods and their applications in neurological and cancer research, with key content from BioTechniques’ digital hub and Taylor & Francis journals, ...

This workshop explored the current use of DNA sequencing in newborns as well as the potential benefits and harms, associated ethical and data security issues, and equity in access to screening. A ...